Tacken, P., Wang, L., Klooster, R., Loo, P. F. V., Zhou, J., Mondal, A., Liu, Y., Kramer, A., Condamine, T., Volgina, A., Hendriks, L., Maaden, H. v. d., Rovers, E., Engels, S., Fransen, F., Blanken-Smit, R. d., Zande, V. Z. d., Basmeleh, A., Bartelink, W., Kulkarni, A., Marissen, W., Huang, C., Hall, L., Harvey, S., Kanellopoulou, C., Stewart, S., Nastri, H., Bakker, L., Logtenberg, T., Plyte, S., Mayes, P., Throsby, M., & Geuijen, C. (n.d.). 820 MCLA-145 is a bispecific IgG1 antibody that inhibits PD-1/PD-L1 signaling while simultaneously activating CD137 signaling on T cells. Journal for immunotherapy of cancer, 8, A870. http://access.bl.uk/ark:/81055/vdc_100144722195.0x000003